Laboratory for Mother and Child Health, Department of Public Health, Mario Negri Institute for Pharmacological Research, Milan, Italy.
BMC Pediatr. 2011 May 23;11:40. doi: 10.1186/1471-2431-11-40.
The safety and effectiveness of psychotropic drug use in the paediatric population is widely debated, in particular because of the lack of data concerning long term effects.In Italy the prevalence of psychotropic drug prescriptions increased in the early 2000s and decreased afterwards. In such a context, a study with the aim to estimate the incidence and prevalence of psychotropic drug prescription in the paediatric population and to describe diagnostic and therapeutic approaches was performed.
The study population was composed of 76,000 youths less than 18 years and living in the area covered by the local health unit of Verona, Italy. The data source was the Verona local health unit's administrative prescription database. Prevalence and incidence of antidepressant and/or antipsychotic drug prescriptions in the 2004-2008 period were estimated. Children and adolescents receiving antidepressant and/or antipsychotic drug prescriptions between 1 January 2005 and 31 December 2006 were identified and questionnaires were sent to the prescribers with the aim to collect data concerning diagnostic and therapeutic approaches, and care strategies.
The prevalence of psychotropic drug prescriptions did not change in the 2004-2008 period, while incidence slightly increased (from 7.0 in 2005 to 8.3 per 10,000 in 2008). Between 1 January 2005 and 31 December 2006, 111 youths received at least one psychotropic drug prescription, 91 of whom received antidepressants. Only 28 patients attended child and adolescent psychiatry services. Information concerning diagnostic and therapeutic approaches, and care strategies was collected for 52 patients (47%). Anxiety-depressive syndrome and attention disorders were the diseases for which psychotropic drugs were most commonly prescribed. In all, 75% youths also received psychological support and 20% were prescribed drugs for 2 or more years.
Despite the low drug prescription prevalence, the finding that most children were not cared for by child and adolescent psychiatric services is of concern and calls for a systematic, continuous monitoring of psychopharmacological treatments.
精神药物在儿科人群中的安全性和有效性存在广泛争议,特别是因为缺乏长期影响的数据。在意大利,精神药物处方的流行率在 21 世纪初上升,之后下降。在这种情况下,进行了一项研究,旨在估计儿科人群中精神药物处方的发生率和流行率,并描述诊断和治疗方法。
研究人群由 76000 名年龄在 18 岁以下、居住在意大利维罗纳地方卫生单位覆盖地区的年轻人组成。数据来源是维罗纳地方卫生单位的行政处方数据库。估计了 2004-2008 年期间抗抑郁药和/或抗精神病药处方的发生率和流行率。确定了 2005 年 1 月 1 日至 2006 年 12 月 31 日期间接受抗抑郁药和/或抗精神病药处方的儿童和青少年,并向处方医生发送了问卷,目的是收集诊断和治疗方法以及护理策略的数据。
2004-2008 年期间,精神药物处方的流行率没有变化,而发病率略有增加(从 2005 年的 7.0 增加到 2008 年的 8.3/10000)。2005 年 1 月 1 日至 2006 年 12 月 31 日期间,111 名年轻人至少接受了一次精神药物处方,其中 91 人接受了抗抑郁药。只有 28 名患者接受了儿童和青少年精神病学服务。共收集了 52 名患者(47%)的诊断和治疗方法以及护理策略信息。焦虑-抑郁综合征和注意力障碍是最常开精神药物的疾病。总共,75%的年轻人还接受了心理支持,20%的人开了 2 年或更长时间的药物。
尽管药物处方的流行率较低,但大多数儿童没有接受儿童和青少年精神病学服务的护理,这令人担忧,需要对精神药理学治疗进行系统、持续的监测。